首页|关于多重耐药菌感染患者临床转归危险因素的Meta分析

关于多重耐药菌感染患者临床转归危险因素的Meta分析

扫码查看
目的 运用Meta分析对影响多重耐药菌感染患者临床转归的各类因素进行综合性判断和系统评价.方法 检索日期为2011年1月1日-2020年12月31日,按照纳入和排除标准筛选文献、提取资料并将评价纳入研究质量,采用RevMan 5.3进行Meta分析.结果 共检索文献438篇,最终纳入研究10篇,不良预后组样本量为638例,好转组样本量为1059例,纳入的影响因素22个.综合分析结果提示,不良预后组和好转组在年龄(95%CI:3.98,6.92)、慢性肾病(95%CI:1.12,3.30)、恶性肿瘤(95%CI:1.15,2.08)、心血管疾病(95%CI:1.15,1.89)、免疫异常(95%CI:1.75,3.27)、机械通气(95%CI:2.51,4.88)、气管插管或气管切开(95%CI:1.17,11.65)、留置导尿管(95%CI:1.10,8.00)、深静脉置管(95%CI:1.76,5.34)、鼻胃管(95%CI:1.03,6.43)、抗菌药物联合应用(95%CI:1.01,2.07)、APACHEⅡ评分(95%CI:1.74,5.85)以及住院时间(95%CI:-13.26,-10.88)等方面的差异均具有统计学意义(P<0.05).结论 高龄,合并基础疾病,有侵入性操作史,抗菌药物联用和APACHE Ⅱ评分越高的多重耐药菌感染患者死亡风险越高、预后越差.应及时判断、识别、应对各类危险因素,采取积极有效措施降低病死率,提高患者生存质量.
Meta-analysis on Risk Factors for Clinical Prognosis in Patients with Multidrug-Resistant Bacterial Infections
Objectives This study aims to use Meta-analysis to conduct a comprehensive judgment and systematic evaluation of various factors that affect the clinical outcomes of patients with multidrug-resistant bacterial infections.Methods Literature was searched from January 1,2011,to December 31,2020,according to inclusion and exclusion criteria to extract data.Evaluation was conducted to assess the research quality.RevMan 5.3 was used for meta-analysis.Results A total of 438 literatures were retrieved and 10 were included in the study,with 638 cases in the poor prognosis group and 1059 cases in the improvement group.22 influencing factors were included.The results of comprehensive analysis revealed statistically significant differences between the poor prognosis group and the improvement group in various factors:age(95%CI:3.98,6.92),chronic kidney disease(95%CI:1.12,3.30),malignant tumors(95%CI:1.15,2.08),cardiovascular diseases(95%CI:1.15,1.89),immune abnormalities(95%CI:1.75,3.27),mechanical ventilation(95%CI:2.51,4.88),endotracheal intubation or tracheostomy(95%CI:1.17,11.65),indwelling urinary catheter(95%CI:1.10,8.00),deep vein catheterization(95%CI:1.76,5.34),nasogastric tube(95%CI:1.03,6.43),antibiotic combination(95%CI:1.01,2.07),APACHE Ⅱ score(95%CI:1.74,5.85),and hospital stays(95%CI:-13.26,-10.88)(P<0.05).Conclusions Patients with multidrug-resistant bacterial infections,particularly those of advanced age,with underlying diseases,a history of invasive procedures,higher antibacterial combination usage,and higher APACHE Ⅱ scores,are at a higher risk of mortality and have a poorer prognosis.Judging,identifying,and responding to various risk factors in a timely manner,and adopting active and effective measures to reduce the mortality rate,are important for improving the quality of life of patients.

Multidrug-resistant infectionClinical prognosisRisk factorMeta-analysis

杨子、刘妍、郑娟、冀翔

展开 >

山西省煤碳中心医院,山西省,太原市,030006

解放军总医院第一医学中心,北京市,100853

山西省肿瘤医院,山西省,太原市,030000

多重耐药菌感染 临床转归 危险因素 Meta分析

2020年度山西省卫生健康委科研课题

2020023

2024

中国病案
中国医院协会

中国病案

CSTPCD
影响因子:1.197
ISSN:1672-2566
年,卷(期):2024.25(7)
  • 1